See the DrugPatentWatch profile for wakix
Harmony Biosciences' Wakix is a medication used to treat excessive daytime sleepiness (EDS) and cataplexy in adults with narcolepsy [1]. It is the first and only FDA-approved wakefulness-promoting medication for these conditions that does not regulate the mesolimbic dopamine pathways [2].
What exactly is Wakix and how does it work?
Wakix is a tablet containing the active ingredient pitolisant [1]. Pitolisant is a first-in-class selective histamine H3 receptor antagonist/inverse agonist. By blocking H3 receptors in the brain, it increases the release of histamine in the brain, which in turn stimulates wakefulness-promoting pathways [2]. This mechanism is thought to reduce EDS and cataplexy associated with narcolepsy [3].
When did Wakix get approved and what does that mean for patients?
The U.S. Food and Drug Administration (FDA) approved Wakix for the treatment of EDS in adults with narcolepsy on August 16, 2019 [1]. Subsequently, it received approval for the treatment of cataplexy in adults with narcolepsy on October 23, 2020 [4]. This dual approval provides patients with narcolepsy a new therapeutic option that targets the underlying neurobiology of the condition [1, 4].
Are there other treatments for narcolepsy that compare to Wakix?
Prior to Wakix, treatment options for narcolepsy primarily involved stimulant medications, which target dopamine pathways, or sodium oxybate. Wakix offers a different mechanism of action by focusing on histamine pathways, potentially providing an alternative for patients who do not respond well to or tolerate other treatments [2].
What are the potential side effects of Wakix?
The most common side effects reported in clinical trials for Wakix include insomnia, nausea, and anxiety [1]. Patients considering Wakix should discuss potential risks and benefits with their healthcare provider.
Who manufactures Wakix and are there any patent concerns?
Harmony Biosciences is the company that developed and markets Wakix [1]. Information regarding the patent status and any potential patent challenges for Wakix can be found on specialized resources like DrugPatentWatch.com [5].
What is the prescription status and cost of Wakix?
Wakix is a prescription medication [1]. The cost of Wakix can vary depending on insurance coverage and pharmacy pricing. Harmony Biosciences may offer patient assistance programs to help eligible individuals with the cost of their medication.
How is Wakix typically prescribed and dosed?
Wakix is administered orally, typically once daily [1]. Dosing regimens are determined by a healthcare professional based on individual patient needs and response.
Sources:
1. https://www.wakix.com/
2. Harmony Biosciences Media Kit
3. Drug Approval Packages
4. FDA Approves Wakix for Cataplexy in Narcolepsy
5. DrugPatentWatch.com